Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10010519539
This paper focuses on the role of large technology companies’ entry and expansion to the data-intensive market areas via their technological development and strategic acquisitions of companies. We analyze the evolvement of personal data related innovation in various data-intensive domains. We...
Persistent link: https://www.econbiz.de/10012164246
This study evaluates the impacts of public subsidies on firms in energy-intensive industries, focusing on R&D subsidies and compensation subsidies. Using firm-level data from Finnish energy-intensive industries between 2010 and 2022, it examines how these subsidies influence firm competitiveness...
Persistent link: https://www.econbiz.de/10015359554
Research and development (R&D) tax credits are widely employed among the OECD countries to promote business sector investments in innovation. The implementation of R&D tax credit schemes, however, varies across countries. The empirical research on the effectiveness of R&D tax incentives suggests...
Persistent link: https://www.econbiz.de/10013179659
Persistent link: https://www.econbiz.de/10009707242
The economic theory of intellectual property rights is based on a rather narrow view of both competition and technological knowledge. We suggest some ways of enriching this framework with a more empirically grounded view of both and, by means of a simulation model, we analyze the impact of...
Persistent link: https://www.econbiz.de/10008732424
The paper attempts a critical assessment of both the theory and the empirical evidence on the role of appropriability and in particular of Intellectual Property Right (IPR) as incentives for technological innovation. We start with a critical discussion of the standard justification of the...
Persistent link: https://www.econbiz.de/10003376037
Persistent link: https://www.econbiz.de/10003407302
Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...
Persistent link: https://www.econbiz.de/10012604733
Persistent link: https://www.econbiz.de/10014463953